Study matching rare cancer care with tumor DNA testing
Part of Cancer clinical trials.
This study looks at people with rare solid tumors or lymphoma to understand their cancer’s genetic changes. It collects blood and existing tissue samples (from standard care) for DNA testing and gathers health information to help improve knowledge about rare cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old when you sign consent.
- You need a rare solid tumor or lymphoma type that is included in the study’s cancer list.
- You must be able and willing to do study blood draws and assessments for the study period.
- You must be able to provide tissue (existing archived tissue and/or new tissue from standard care) and blood for genetic testing; tissue must be recent enough for testing.
- Your day-to-day functioning must be good (ECOG 0–2), and you must be able to read, write, and communicate in English.
- You must live in the United States and be able to sign a web-based or clinic consent form.
- You cannot be pregnant or breastfeeding, and you must be able to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects and analyzes genetic information from tissue or blood samples to help understand cancer and related inherited (family) risk. It may involve testing results being shared with you or your care team, depending on what samples are available.
This study looks at your tumor’s molecular (DNA/biologic) features to better understand metastatic breast cancer in people under 50. You may help researchers by providing tissue samples (biopsies) for lab testing.
This study looks at the genetic information (DNA) from your blood and from saved tumor tissue to better understand certain cancers, especially rare cancers with a poor outlook. It may help researchers learn why these cancers behave the way they do and guide future treatments.
This study follows people (and sometimes family members) connected to rare solid tumors and collects health information and samples (biospecimens). It helps researchers understand how these cancers develop and builds resources for future research, which may benefit you by contributing to better tailored care for rare cancers.
This trial tests new experimental cancer treatments and technologies for people with rare or hard-to-treat tumors. It aims to find tailored therapies that may work better for your specific cancer. You will be asked to provide a tumor sample for testing, and the trial team will guide you through the process.
This study uses advanced DNA testing on tumor samples to help match cancer treatments more precisely. It may help researchers learn which cancer changes are driving your tumor and how they relate to treatment choices.
Hear when a new Cholangiocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.